Guardant Health (NASDAQ:GH) Given New $35.00 Price Target at Sanford C. Bernstein
Guardant Health (NASDAQ:GH – Free Report) had its price objective decreased by Sanford C. Bernstein from $40.00 to $35.00 in a report released on Wednesday, Benzinga reports. Sanford C. Bernstein currently has an outperform rating on the stock. Other analysts have also issued research reports about the company. Bank of America raised their target price […]
31 Oct 10:20 · The Markets Daily